Stuart Paynter
Direttore Finanziario/CFO presso OXFORD BIOMEDICA PLC
Patrimonio netto: 64 698 $ in data 30/04/2024
Posizioni attive di Stuart Paynter
Società | Posizione | Inizio | Fine |
---|---|---|---|
OXFORD BIOMEDICA PLC | Direttore/Membro del Consiglio | 29/08/2017 | - |
Direttore Finanziario/CFO | 29/08/2017 | - | |
Public Communications Contact | - | - | |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Corporate Officer/Principal | - | - |
Oxford Biomedica (UK) Ltd.
Oxford Biomedica (UK) Ltd. BiotechnologyHealth Technology Part of Oxford Biomedica Plc, Oxford Biomedica (UK) Ltd. is a viral vector contract development and manufacturing organization (CDMO) based in Oxford, UK. Oxford Biomedica (UK has over 25 years of experience in the industry and is committed to enabling its clients to deliver life-changing therapies to patients worldwide. The British company offers innovative solutions to cell and gene therapy biotechnology and biopharma companies by working across key viral vector delivery systems including adeno-associated virus (AAV) and lentiviral delivery system. | Direttore/Membro del Consiglio | - | - |
Segretario Aziendale | - | - | |
Oxxon Therapeutics Ltd.
Oxxon Therapeutics Ltd. BiotechnologyHealth Technology Part of Oxford Biomedica Plc, Oxxon Therapeutics Ltd. is a biotechnology company. Oxxon Therapeutics Ltd. is based in Oxford, UK. Oxxon Therapeutics was acquired by Oxford Biomedica Plc on March 15, 2007 for $24.89 million. The British company was founded in 1998. | Direttore/Membro del Consiglio | 29/08/2017 | - |
Storia della carriera di Stuart Paynter
Precedenti posizioni note di Stuart Paynter
Società | Posizione | Inizio | Fine |
---|---|---|---|
DE LA RUE PLC | Corporate Officer/Principal | 01/03/2016 | 01/07/2021 |
Shire Pharmaceuticals Ltd.
Shire Pharmaceuticals Ltd. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Ltd. is a patient-focused, British innovation-driven pharmaceutical company. The company is based in London, UK. Takeda has a distinguished 240-year history and aspires to bring better health and a brighter future for people worldwide. Shire Pharmaceuticals was founded in 1986. The CEO is Flemming Ørnskov. | Direttore Finanziario/CFO | 01/08/2007 | 01/02/2016 |
STERIS Ltd.
STERIS Ltd. Medical SpecialtiesHealth Technology STERIS Ltd. engages in the provision of infection prevention and other procedural products and services. It operates through the following segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers infection prevention and procedural solutions for healthcare providers worldwide, including capital equipment, and related maintenance and installation services, as well as consumables. The Healthcare Specialty Services segment provides a range of specialty services for healthcare providers including hospital sterilization services, instrument and scope repairs, and linen management. The Life Sciences segment gives capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities. The Applied Sterilization Technologies segment involves in contract sterilization and laboratory services for medical device and pharmaceutical Customers and others. The company was founded on October 9, 2014 and is headquartered in Chaddesden, the United Kingdom. | Corporate Officer/Principal | 01/01/2001 | 01/07/2007 |
Formazione di Stuart Paynter
Imperial College London | Undergraduate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 9 |
Posizioni
Director/Board Member | 3 |
Corporate Officer/Principal | 3 |
Director of Finance/CFO | 2 |
Settori
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
OXFORD BIOMEDICA PLC | Health Technology |
DE LA RUE PLC | Commercial Services |
Aziende private | 5 |
---|---|
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Commercial Services |
Shire Pharmaceuticals Ltd.
Shire Pharmaceuticals Ltd. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Ltd. is a patient-focused, British innovation-driven pharmaceutical company. The company is based in London, UK. Takeda has a distinguished 240-year history and aspires to bring better health and a brighter future for people worldwide. Shire Pharmaceuticals was founded in 1986. The CEO is Flemming Ørnskov. | Health Technology |
STERIS Ltd.
STERIS Ltd. Medical SpecialtiesHealth Technology STERIS Ltd. engages in the provision of infection prevention and other procedural products and services. It operates through the following segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers infection prevention and procedural solutions for healthcare providers worldwide, including capital equipment, and related maintenance and installation services, as well as consumables. The Healthcare Specialty Services segment provides a range of specialty services for healthcare providers including hospital sterilization services, instrument and scope repairs, and linen management. The Life Sciences segment gives capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities. The Applied Sterilization Technologies segment involves in contract sterilization and laboratory services for medical device and pharmaceutical Customers and others. The company was founded on October 9, 2014 and is headquartered in Chaddesden, the United Kingdom. | Health Technology |
Oxford Biomedica (UK) Ltd.
Oxford Biomedica (UK) Ltd. BiotechnologyHealth Technology Part of Oxford Biomedica Plc, Oxford Biomedica (UK) Ltd. is a viral vector contract development and manufacturing organization (CDMO) based in Oxford, UK. Oxford Biomedica (UK has over 25 years of experience in the industry and is committed to enabling its clients to deliver life-changing therapies to patients worldwide. The British company offers innovative solutions to cell and gene therapy biotechnology and biopharma companies by working across key viral vector delivery systems including adeno-associated virus (AAV) and lentiviral delivery system. | Health Technology |
Oxxon Therapeutics Ltd.
Oxxon Therapeutics Ltd. BiotechnologyHealth Technology Part of Oxford Biomedica Plc, Oxxon Therapeutics Ltd. is a biotechnology company. Oxxon Therapeutics Ltd. is based in Oxford, UK. Oxxon Therapeutics was acquired by Oxford Biomedica Plc on March 15, 2007 for $24.89 million. The British company was founded in 1998. | Health Technology |
- Borsa valori
- Insiders
- Stuart Paynter
- Esperienza